<DOC>
	<DOCNO>NCT01603745</DOCNO>
	<brief_summary>Polycystic ovary syndrome ( PCOS ) often associate pathological condition , insulin resistance ( IR ) , type 2 diabetes ( DM2 ) , obesity potentially increase risk cardiovascular disease ( CVD ) . Of note , risk factor CVD include dyslipidaemia , hypertension , oxidative stress inflammation associate PCOS . The investigator want evaluate effect two different type E/P therapy cardiovascular risk PCOS .</brief_summary>
	<brief_title>Effects Drospirenone-ethinylestradiol and/or NOMAC-valerate Estradiol Cardiovascular Risk Women With Polycystic Ovary Syndrome</brief_title>
	<detailed_description>PCOS common female endocrinopathy reproductive age . This syndrome heterogeneous condition characterize several symptom clinical sign related reproductive , cardiometabolic psychological disorders.We recently demonstrate young PCOS woman show expansion unusual T-cell population proinflammatory function , identify CD4+CD28null T lymphocytes . Of note , T subpopulation find expand patient unstable angina , type 2 diabetes ( DM2 ) , absence clinical evidence CVD 12 , recently associate recurrent coronary instability .Based mentioned evidence , aim present study evaluate effect DRPS/EE alone versus metformin alone versus DRPS/EE plus metformin CD4+CD28null T cell frequency endocrino-metabolic parameter , hyperinsulinemic PCOS patientsTo evaluate long-term effect drospirenone ( DRSP ) /ethinylestradiol ( EE ) NOMAC-valerate estardiol cardiovascular risk factor PCOS patient .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Polycystic Ovary Syndrome</mesh_term>
	<mesh_term>Drospirenone</mesh_term>
	<mesh_term>Ethinyl Estradiol</mesh_term>
	<mesh_term>Estradiol</mesh_term>
	<mesh_term>Drospirenone ethinyl estradiol combination</mesh_term>
	<criteria>patient PCOS age 1835 year chronic acute inflammatory disease cancer autoimmune disease treatment clomiphene citrate antiandrogens drug control appetite insulinsensitizing drug ( metformin , pioglitazone rosiglitazone ) last 6 month prior evaluation , DM2 , hypertension , major surgery last 3 month hormonal dysfunction ( hypothalamic , pituitary , thyroidal , adrenal cause )</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>May 2012</verification_date>
	<keyword>PCOS</keyword>
</DOC>